Cedars-Sinai Medical Center

medical staff pulse newsletter

Text size: A A A
A BI-WEEKLY PUBLICATION FROM THE CEDARS-SINAI CHIEF OF STAFF May 20, 2016 | Archived Issues

P & T Approvals

Pharmacy Focus

Highlights of the April meeting of the Pharmacy and Therapeutics Committee are summarized in the PDF link below.

P and T Approvals - April 2016 (PDF)


Meetings and Events


Grand Rounds

Click here to view upcoming grand rounds.


Upcoming CME Conferences

Click below to view a complete list of all scheduled Continuing Medical Education conferences.

CME Newsletter - May 2016 (PDF)  


Milestones

Myron Isaacs, MD, has died.

» Read more

Share Your News

Won any awards or had an article accepted for publication? Share your news about professional achievements and other items of interest.

Click here to share your news

New Test Helps Detect Pregnancy Complications

A faster, more accurate and less invasive test to help detect the premature rupture of membranes in pregnancy began rolling out at Cedars-Sinai in May.

The Core Lab began using the AmniSure test on Wednesday, May 18, to check for complications of premature rupture of the fetal membrane, which can include infection, umbilical prolapse, placental abruption and preterm delivery.

The preterm condition is marked by the spontaneous rupture of the membranes at less than 37 weeks of gestation and at least one hour before the onset of contractions.

Standard diagnostic methods, including nitrazine, ferning, pooling and ultrasound, alone or in combination, are often not sufficient or accurate when diagnosing the pregnant patient suspected of having ruptured membranes.

By identifying a protein called placental alpha microglobulin-1 (PAMG-1) in the vaginal fluids of a pregnant patient, the new test can help determine whether a rupture might have occurred.

Swabs collected for testing should be transported immediately to the Core Lab to ensure timely results and minimal protein degradation for accurate interpretation (i.e., less than 30 minutes).

If you have questions, contact Kimia Sobhani, PhD, at Kimia.sobhani@cshs.org or Holli Mason, MD, at Holli.mason@cshs.org.